XML 24 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash Flows from Operating Activities    
Net loss $ (9,200,058) $ (3,910,234)
Adjustments to reconcile net loss to net cash used in operating activities:    
Materials cost in connection with license activity 6,287 1,082,626
Warrants issued in connection with transfer agreement   37,840
Stock-based compensation 627,847 90,952
Amortization of beneficial conversion feature   6,250
Accretion of debt discount 2,419,831 5,514
Revaluation of warrant liability 501,617  
Amortization of deferred finance charge 86,667 3,894
Changes in assets and liabilities:    
Accounts receivable (29,387)  
Inventory (108,695)  
Prepaid license fee   100,000
Prepaid expenses (124,944) (32,998)
Other long-term assets (122,163)  
Due to/from parent (21,815) (53,328)
Deferred revenue 349,791  
License fee payable (175,000)  
Accounts payable (370,984) 193,196
Accrued expenses (869,580) 699,423
Total cash used in operations (7,030,586) (1,776,865)
Cash Flows from Investing Activities    
Purchase of equipment   (55,149)
Total Cash Used in Investing Activities   (55,149)
Cash Flows from Financing Activities    
Proceeds from issuance of redeemable convertible preferred stock, net   6,658,241
Repayment of convertible notes payable (100,000)  
Repayment of notes payable (1,000,000)  
Proceeds from issuance of redeemable convertible notes payable, net 1,250,000 300,000
Proceeds from issuance of commom stock in initial public offering, net 18,810,484  
Deferred offering costs (396,012) (1,029,896)
Total Cash Provided by Financing Activities 18,564,472 5,928,345
Net increase in cash and cash equivalents 11,533,886 4,096,331
Cash and cash equivalents, beginning of period 845,192 [1] 185,367
Cash and cash equivalents, end of period 12,379,078 4,281,698
Supplemental Schedule of Non-Cash Financing and Investing Activities    
Offering costs not paid during the period 1,401,253  
Equipment received in connection with license agreement   817,374
Notes payable converted into common stock   525,000
Warrants issued in connection with convertible notes payable 47,479  
Conversion of convertible preferred stock to common stock 7,651,288  
Conversion preferred stock warrant liability to common stock warrants 1,150,985  
Conversion of convertible notes to common stock 2,100,000  
Accretion of redeemable convertible preferred stock 346,374 $ 285,009
Abatement of license fee payable to Napo $ 250,000  
[1] The condensed balance sheet at December 31, 2014 is derived from the audited financial statements at that date included in the Company's prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) on May 14, 2015.